ENHANCING MEDICATION ADHERENCE THROUGH DIGITAL HEALTH APPS: INNOVATIONS IN PATIENT-CENTERED CARE
Keywords:
Digital health applications; Medication adherence; Mobile health (mHealth); Artificial intelligence; Patient engagement; Telehealth; Wearable technologies; Remote patient monitoring; Digital therapeutics; Patient-centered healthcare.Abstract
Digital health applications have become essential tools for promoting medication adherence, improving patient engagement, and enhancing healthcare delivery across a wide range of clinical settings. Medication nonadherence continues to be a significant global health concern, contributing to poor clinical outcomes, increased hospitalizations, higher mortality rates, and escalating healthcare costs. Advances in mobile health technologies, wearable devices, cloud computing, artificial intelligence (AI), machine learning, and telehealth have accelerated the development of innovative digital solutions that support medication management through reminders, adherence monitoring, personalized interventions, electronic prescribing, and remote patient care. These applications facilitate patient-centered healthcare by integrating features such as medication scheduling, symptom monitoring, teleconsultation services, educational resources, electronic health record connectivity, and real-time communication between patients and healthcare providers. AI-driven analytics further strengthen these platforms by enabling predictive risk assessment, customized medication plans, automated alerts, and intelligent decision support. Evidence from clinical studies demonstrates that digital adherence interventions can significantly improve treatment compliance among individuals with chronic conditions, including diabetes, hypertension, cardiovascular diseases, HIV infection, and mental health disorders. The COVID-19 pandemic further accelerated the adoption of digital healthcare technologies by highlighting the value of remote monitoring and virtual healthcare services. Nevertheless, several challenges continue to impede widespread implementation, including concerns related to data privacy, cybersecurity, digital literacy, interoperability, long-term patient engagement, healthcare equity, and regulatory variability, particularly in resource-limited settings. This review examines the evolution of digital health applications for medication adherence, discusses their technological innovations and clinical applications, evaluates their benefits and limitations, and explores future directions, with particular emphasis on artificial intelligence, wearable technologies, gamification, and remote monitoring systems in advancing patient-centered healthcare and improving long-term therapeutic adherence.
Downloads
References
1. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
2. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86:304-14.
3. Free C, Phillips G, Watson L, et al. The effectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis. PLoS Med. 2013;10:e1001363.
4. Ventola CL. Mobile devices and apps for health care professionals: uses and benefits. P T. 2014;39:356-64.
5. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25:44-56.
6. Keesara S, Jonas A, Schulman K. Covid-19 and health care’s digital revolution. N Engl J Med. 2020;382:e82.
7. Kruse CS, Frederick B, Jacobson T, et al. Cybersecurity in healthcare: a systematic review of modern threats and trends. Technol Health Care. 2017;25:1-10.
8. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.
9. Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382:1679-81.
10. Iyengar K, Upadhyaya GK, Vaishya R, et al. COVID-19 and applications of digital health. Diabetes Metab Syndr. 2020;14:733-7.
11. Santo K, Richtering SS, Chalmers J, et al. Mobile phone apps to improve medication adherence: a systematic stepwise process to identify high-quality apps. NPJ Digit Med. 2019;2:1-9.
12. Dorsey ER, Topol EJ. State of telehealth. N Engl J Med. 2016;375:154-61.
13. Steinhubl SR, Muse ED, Topol EJ. Digital medicine and wearable technologies. Lancet. 2015;386:1905-12.
14. Jiang F, Jiang Y, Zhi H, et al. Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol. 2017;2:230-43.
15. Bickmore TW, Pfeifer LM, Byron D, et al. Usability of conversational agents by patients with inadequate health literacy: evidence from two clinical trials. Patient Educ Couns. 2010;80:315-20.
16. Hou C, Xu Q, Diao S, et al. Mobile phone applications and self-management of diabetes: a systematic review with meta-analysis, meta-regression of 21 randomized trials. Int J Med Inform. 2018;120:106-15.
17. Morawski K, Ghazinouri R, Krumme A, et al. Association of a smartphone application with medication adherence and blood pressure control: the MedISAFE-BP randomized clinical trial. JAMA Intern Med. 2018;178:802-9.
18. Firth J, Torous J, Nicholas J, et al. The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry. 2017;16:287-98.
19. Thakkar J, Kurup R, Laba TL, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med. 2016;176:340-9.
20. Cutler RL, Fernandez-Llimos F, Frommer M, et al. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8:e016982.
21. Mehrotra A, Ray K, Brockmeyer DM, et al. Rapidly converting to “virtual practices”: outpatient care in the era of Covid-19. NEJM Catal Innov Care Deliv. 2020;1:1-5.
22. Cugelman B. Gamification: what it is and why it matters to digital health behavior change developers. JMIR Serious Games. 2013;1:e3.
23. McGraw D. Building public trust in uses of Health Insurance Portability and Accountability Act de-identified data. Health Aff (Millwood). 2013;32:1699-705.
24. Perski O, Blandford A, West R, et al. Conceptualising engagement with digital behaviour change interventions: a systematic review using principles from critical interpretive synthesis. Transl Behav Med. 2017;7:254-67.
25. Poudel A, Nissen LM. Telepharmacy: a pharmacist’s perspective on the clinical benefits and challenges. Aust J Rural Health. 2016;24:236-41.
26. Bashshur RL, Shannon GW, Smith BR, et al. The empirical foundations of telemedicine interventions for chronic disease management. Telemed J E Health. 2014;20:769-800.
27. Fatehi F, Samadbeik M, Kazemi A. What is digital health? review of definitions. BMJ Health Care Inform. 2020;27:e100275.
28. Topol EJ. Deep medicine: how artificial intelligence can make healthcare human again. New York: Basic Books; 2019.
29. Nouri S, Khoong EC, Lyles CR, et al. Addressing equity in telemedicine for chronic disease management during the Covid-19 pandemic. NEJM Catal Innov Care Deliv. 2020;1:1-13.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
(CC BY-NC)
. 